Official Diabetes Statistics

Official Diabetes Statistics

Diabetes Statistics in the United States

What is diabetes?
Prevalence of diabetes
Incidence of diabetes
Deaths among people with diabetes
Prevalence of diabetes by age
Prevalence of diabetes by sex in people 20 years or older
Prevalence of diabetes by race/ethnicity in people 20 years or older
The four types of diabetes
Complications of diabetes
Cost
New diagnostic criteria for diabetes
Treatment of diabetes
Impaired fasting glucose
Appendix
References
Acknowledgments

What is diabetes?

Diabetes mellitus is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin secretion, insulin action, or both. Diabetes can be associated with serious complications and premature death, but people with diabetes can take measures to reduce the likelihood of such occurrences.

Prevalence of diabetes*

Total: 15.7 million people--5.9 percent of the population--have diabetes.

Diagnosed:

Undiagnosed:

* For further information on prevalence, see the Appendix.

Incidence of diabetes

New cases diagnosed per year: 798,000.

Deaths among people with diabetes

Studies have found death rates to be twice as high among middle-aged people with diabetes as among middle-aged people without diabetes.
Based on death certificate data, diabetes contributed to 193,140 deaths in 1996.
Diabetes was the seventh leading cause of death listed on U.S. death certificates in 1996.
Diabetes is believed to be underreported on death certificates, both as a condition and as a cause of death.

Prevalence of diabetes by age

Age 65 years or older: 6.3 million. 18.4 percent of all people in this age group have diabetes.

Age 20 years or older: 15.6 million. 8.2 percent of all people in this age group have diabetes.

Under age 20: 123,000. 0.16 percent of all people in this age group have diabetes.

Prevalence of diabetes by sex in people 20 years or older*

Men: 7.5 million. 8.2 percent of all men have diabetes.

Women: 8.1 million. 8.2 percent of all women have diabetes.

*These figures do not include the approximately 123,000 cases of diabetes in children and teenagers in the United States.

Prevalence of diabetes by race/ethnicity in people 20 years or older

Non-Hispanic whites: 11.3 million. 7.8 percent of all non-Hispanic whites have diabetes.

Non-Hispanic blacks: 2.3 million. 10.8 percent of all non-Hispanic blacks have diabetes. On average, non-Hispanic blacks are 1.7 times as likely to have diabetes as non-Hispanic whites of similar age.

Mexican Americans: 1.2 million. 10.6 percent of all Mexican Americans have diabetes. On average, Mexican Americans are 1.9 times as likely to have diabetes as non-Hispanic whites of similar age.

Other Hispanic/Latino Americans: On average, Hispanic/Latino Americans are almost twice as likely to have diabetes as non-Hispanic whites of similar age. (Sufficient data are not currently available to derive more specific estimates.)

American Indians and Alaska Natives: 9 percent of American Indians and Alaska Natives have diagnosed diabetes. On average, American Indians and Alaska Natives are 2.8 times as likely to have diagnosed diabetes as non-Hispanic whites of similar age.

Asian Americans and Pacific Islanders: Prevalence data for diabetes among Asian Americans and Pacific Islanders are limited. Some groups within this population are at increased risk for diabetes. For example, data collected from 1988 to 1995 suggest that Native Hawaiians are twice as likely to have diagnosed diabetes as white residents of Hawaii.

The four types of diabetes

Type 1 diabetes was previously called insulin-dependent diabetes mellitus (IDDM) or juvenile-onset diabetes. Type 1 diabetes may account for 5 to 10 percent of all diagnosed cases of diabetes. Risk factors are less well defined for type 1 diabetes than for type 2 diabetes, but autoimmune, genetic, and environmental factors are involved in the development of this type of diabetes.

Type 2 diabetes was previously called non-insulin-dependent diabetes mellitus (NIDDM) or adult-onset diabetes. Type 2 diabetes may account for about 90 to 95 percent of all diagnosed cases of diabetes. Risk factors for type 2 diabetes include older age, obesity, family history of diabetes, prior history of gestational diabetes, impaired glucose tolerance, physical inactivity, and race/ethnicity. African Americans, Hispanic/Latino Americans, American Indians, and some Asian Americans and Pacific Islanders are at particularly high risk for type 2 diabetes.

Gestational diabetes develops in 2 to 5 percent of all pregnancies but disappears when a pregnancy is over. Gestational diabetes occurs more frequently in African Americans, Hispanic/Latino Americans, American Indians, and persons with a family history of diabetes. Obesity is also associated with higher risk. Women who have had gestational diabetes are at increased risk for later developing type 2 diabetes. In some studies, nearly 40 percent of women with a history of gestational diabetes developed diabetes in the future.

"Other specific types" of diabetes result from specific genetic syndromes, surgery, drugs, malnutrition, infections, and other illnesses. Such types of diabetes may account for 1 to 2 percent of all diagnosed cases of diabetes.

Complications of diabetes

Heart disease

Heart disease is the leading cause of diabetes-related deaths. Adults with diabetes have heart disease death rates about 2 to 4 times as high as those of adults without diabetes.

Stroke

The risk of stroke is 2 to 4 times higher in people with diabetes.

High blood pressure

An estimated 60 to 65 percent of people with diabetes have high blood pressure.

Blindness

Diabetes is the leading cause of new cases of blindness in adults 20 to 74 years old.
Diabetic retinopathy causes from 12,000 to 24,000 new cases of blindness each year.

Kidney disease

Diabetes is the leading cause of end-stage renal disease, accounting for about 40 percent of new cases.
27,851 people with diabetes developed end-stage renal disease in 1995.
In 1995, a total of 98,872 people with diabetes underwent dialysis or kidney transplantation.

Nervous system disease

About 60 to 70 percent of people with diabetes have mild to severe forms of nervous system damage (which often includes impaired sensation or pain in the feet or hands, slowed digestion of food in the stomach, carpal tunnel syndrome, and other nerve problems).
Severe forms of diabetic nerve disease are a major contributing cause of lower extremity amputations.

Amputations

More than half of lower limb amputations in the United States occur among people with diabetes.
From 1993 to 1995, about 67,000 amputations were performed each year among people with diabetes.

Dental disease

Periodontal disease (a type of gum disease that can lead to tooth loss) occurs with greater frequency and severity among people with diabetes. Periodontal disease has been reported to occur among 30 percent of people age 19 years or older with type 1 diabetes.

Complications of pregnancy

The rate of major congenital malformations in babies born to women with preexisting diabetes varies from 0 to 5 percent among women who receive preconception care to 10 percent among women who do not receive preconception care.
Between 3 and 5 percent of pregnancies among women with diabetes result in death of the newborn; the rate for women who do not have diabetes is 1.5 percent.

Other complications

Diabetes can directly cause acute life-threatening events, such as diabetic ketoacidosis* and hyperosmolar nonketotic coma.*
People with diabetes are more susceptible to many other illnesses. For example, they are more likely to die of pneumonia or influenza than people who do not have diabetes.

*Diabetic ketoacidosis and hyperosmolar nonketotic coma are medical conditions that can result from biochemical imbalance in uncontrolled diabetes.

Cost

Total (direct and indirect): $98 billion (United States, 1997).

Direct medical costs: $44 billion.

Indirect costs: $54 billion (disability, work loss, premature mortality).

This estimate, provided by the American Diabetes Association, is in contrast to higher estimates cited elsewhere that are based on all health care costs incurred by people with diabetes, including costs not resulting from diabetes.

New diagnostic criteria for diabetes*

The new diagnostic criteria for diabetes include the following changes:

The routine diagnostic test for diabetes is now a fasting plasma glucose test rather than the previously recommended oral glucose tolerance test. (However, in certain clinical circumstances, physicians may still choose to perform the oral glucose tolerance test.)
A confirmed** fasting plasma glucose value of greater than or equal to 126 milligrams/deciliter (mg/dL) indicates a diagnosis of diabetes. Previously, a value of greater than or equal to 140 mg/dL had been required for diagnosis.
In the presence of symptoms of diabetes, a confirmed** nonfasting plasma glucose value of greater than or equal to 200 mg/dL indicates a diagnosis of diabetes.
When a doctor chooses to perform an oral glucose tolerance test (by administering 75 grams of anhydrous glucose dissolved in water, in accordance with World Health Organization standards, and then measuring the plasma glucose concentration 2 hours later), a confirmed** glucose value of greater than or equal to 200 mg/dL indicates a diagnosis of diabetes.

In pregnant women, different requirements are used to identify the presence of gestational diabetes.

*For further information about the new diagnostic criteria for diabetes, please see the "Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus," in the References.

**Except in certain specified circumstances, abnormal tests must be confirmed by repeat testing on another day.

Treatment of diabetes

Diabetes knowledge, treatment, and prevention strategies advance daily. Treatment is aimed at keeping blood glucose near normal levels at all times. Training in self-management is integral to the treatment of diabetes. Treatment must be individualized and must address medical, psychosocial, and lifestyle issues.

Treatment of type 1 diabetes: Lack of insulin production by the pancreas makes type 1 diabetes particularly difficult to control. Treatment requires a strict regimen that typically includes a carefully calculated diet, planned physical activity, home blood glucose testing several times a day, and multiple daily insulin injections.
Treatment of type 2 diabetes: Treatment typically includes diet control, exercise, home blood glucose testing, and, in some cases, oral medication and/or insulin. Approximately 40 percent of people with type 2 diabetes require insulin injections.

Impaired fasting glucose

Impaired fasting glucose is a new diagnostic category in which persons have fasting plasma glucose values of 110–125 mg/dL. These glucose values are greater than the level considered normal but less than the level that is diagnostic of diabetes. It is estimated that 13.4 million adults, 7.0 percent of this population, have impaired fasting glucose. Scientists are trying to learn how to predict which of these persons will go on to develop diabetes and how to prevent such progression.

Appendix

How were the estimates in this fact sheet derived?
Periodically, the Federal Government conducts surveys to determine the health of Americans. Such surveys involve questionnaires and medical tests. Most of the diabetes prevalence and incidence estimates presented in this fact sheet were developed by analyzing the newest available national survey data and then adjusting for changes in the population based on 1997 census estimates. The prevalence of diagnosed diabetes represents the number who said they had diabetes. The prevalence of undiagnosed diabetes represents the number of people who said they did not have diabetes, but when given a fasting plasma glucose test, they did in fact have abnormally elevated blood glucose levels (defined as fasting plasma glucose levels greater than or equal to 126 mg/dL). Other estimates presented in this fact sheet were based on individual surveys, research projects, and registry data. A listing of references and additional data sources is below. Most of the national diabetes prevalence estimates are based on Harris MI, et al.

Has the number of persons with diabetes changed since the Diabetes Statistics Fact Sheet issued in 1995?
Between the 1995 and 1997 fact sheets, the number of persons with diagnosed diabetes increased from 8 million to 10.3 million, but the number of persons with undiagnosed diabetes decreased. For the 1995 Diabetes Statistics Fact Sheet, the number of persons with undiagnosed diabetes was estimated from research using the oral glucose tolerance test to identify undiagnosed diabetes. In contrast, for the present Diabetes Statistics Fact Sheet, the number of persons with undiagnosed diabetes was estimated from research using the fasting plasma glucose test, according to recently enacted recommendations. These tests are not equivalent, however, and fewer cases of undiagnosed diabetes are identified using the fasting plasma glucose test.

An enhanced national effort to identify previously undiagnosed persons may also have contributed to a decrease in the number of persons with undiagnosed diabetes. Continued efforts to identify persons with undiagnosed diabetes, the implementation of new guidelines for screening, and the use of an easier and less expensive diagnostic test are all likely to lead to even further decreases in the number of persons with undiagnosed diabetes and increases in the number of persons with diagnosed diabetes.

References

American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 1998; 21(2): 296-309.

Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. Diabetes Care 1998; 21(4): 518-524.

National Diabetes Data Group, National Institutes of Health. Diabetes in America, 2nd Edition. Bethesda, MD: National Institutes of Health, 1995. NIH Publication No. 95-1468.

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20(7):1183-1197.

U.S. Department of Health and Human Services. Physical Activity and Health: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 1996.

U.S. Renal Data System. USRDS 1997 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1997.

Acknowledgments

The following organizations collaborated in compiling the information for this fact sheet:

American Association of Diabetes Educators
http://www.aadenet.org

American Diabetes Association
http://www.diabetes.org

Centers for Disease Control and Prevention
http://www.cdc.gov/diabetes
http://www.cdc.gov/nchswww

Department of Veterans Affairs
http://www.va.gov/health/diabetes

Health Resources and Services Administration
http://www.hrsa.dhhs.gov

Indian Health Service
http://www.ihs.gov

Juvenile Diabetes Foundation International
http://www.jdfcure.org

National Council of La Raza
http://www.nclr.org

National Diabetes Education Program: A joint program of NIH & CDC
http://ndep.nih.gov
http://www.cdc.gov/diabetes

National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health
http://www.niddk.nih.gov

U.S. Department of Health and Human Services Office of Minority Health
http://www.omhrc.gov

National Diabetes Information Clearinghouse

1 Information Way
Bethesda, MD 20892-3560
E-mail: National Diabetes Information Clearinghouse

The National Diabetes Information Clearinghouse (NDIC) is a service of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). NIDDK is part of the National Institutes of Health under the U.S. Department of Health and Human Services. Established in 1978, the clearinghouse provides information about diabetes to people with diabetes and their families, health care professionals, and the public. NDIC answers inquiries; develops, reviews, and distributes publications; and works closely with professional and patient organizations and Government agencies to coordinate resources about diabetes.

Publications produced by the clearinghouse are reviewed carefully for scientific accuracy, content, and readability.

This e-text is not copyrighted. The clearinghouse encourages users of this e-pub to duplicate and distribute as many copies as desired.

NIH Publication No. 99-3892
March 1999

e-text posted: September 1999

The Links Below Jump To Pages On Whatever Web You Are In
Table Of Contents	Search This Web		Navigation Help Page
Write To Karl Loren -- He Pledges To Answer EVERY Personal Message, Personally. Click here or on his name in the box below.
The Links Below Are To Various Web Sites Published By Karl Loren
Karl Loren Web	Vibrant Life Web		Karl Loren's Book
Super Colostrum	Bulk MSM		Heart Disease
Emmessar	Happiness		Arthritis
Instead Of	Chelation Therapy		Super Colostrum (2)
Karl Loren's Catalog Store		Central Page For All 12 Webs!

SUBSCRIBE: The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren. You can view more than 50 back issues of this publication by clicking here. The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter. It is automatically published on the Tuesday night just before the first Wednesday of every month. You can subscribe to this free monthly electronic letter by entering your eMail address and name below. You will then automatically receive a request for confirmation, sent to whatever address you have entered. If you do NOT receive this confirmation request, then you will not be subscribed. There may have been an error with your address and you should resubmit. The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription. When you receive this confirmation request you must reply to it, or your subscription will not become active. No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.

REMOVAL: You can remove yourself from the subscription list in several different ways. Click here to read about this entire newsletter system. Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list. If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed. Thus, no one else can unsubscribe you, from some other computer, without your knowledge. But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.

Personal Message: When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions. Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US. You can select particular information you would like to receive, along with the free cassette tape and catalog.

Home Page -- Karl Loren Web Site Navigation Bar
Karl Loren Diet	Cancer & Biopsies	Oral Chelation	High Cholesterol Risk Factor
Karl Loren's Personal Diet Diary	Ultrasound Technology	Karl Loren Personal	Plaque Isn't Where They Say It Is
Aajonus Vonderplanitz	Arthritis	Karl's Adventure With The IRS	Bones Are Alive
Diabetes	Table Of Contents	Jean Ross	Witch Doctors & Ethnobotany
Sugar	Shopping Cart Order	Karl Loren's Book On Heart Disease	AIDS
Raw Milk	Search This Web	Write To Karl Loren	Right To Die
Why You Should Drink More Water	Transfer Factor & The Immune System	What Is A Free Radical?	Methyl Sulfonyl Methane
Taheebo Tea	Germanium	Corruption In The American Heart Association	James Coburn's Use Of MSM To Handle Arthritis
Floaters Rather Than Sinkers	Toxic Metals	Heart Disease	Jimmy Keller -- Forbidden Medicine


	What is diabetes? Prevalence of diabetes Incidence of diabetes Deaths among people with diabetes Prevalence of diabetes by age Prevalence of diabetes by sex in people 20 years or older Prevalence of diabetes by race/ethnicity in people 20 years or older The four types of diabetes Complications of diabetes Cost New diagnostic criteria for diabetes Treatment of diabetes Impaired fasting glucose Appendix References Acknowledgments
What is diabetes?	Diabetes mellitus is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin secretion, insulin action, or both. Diabetes can be associated with serious complications and premature death, but people with diabetes can take measures to reduce the likelihood of such occurrences.
Prevalence of diabetes*	Total: 15.7 million people--5.9 percent of the population--have diabetes. Diagnosed: 10.3 million people Undiagnosed: 5.4 million people * For further information on prevalence, see the Appendix.
Incidence of diabetes	New cases diagnosed per year: 798,000.
Deaths among people with diabetes	Studies have found death rates to be twice as high among middle-aged people with diabetes as among middle-aged people without diabetes. Based on death certificate data, diabetes contributed to 193,140 deaths in 1996. Diabetes was the seventh leading cause of death listed on U.S. death certificates in 1996. Diabetes is believed to be underreported on death certificates, both as a condition and as a cause of death.
Prevalence of diabetes by age	Age 65 years or older: 6.3 million. 18.4 percent of all people in this age group have diabetes. Age 20 years or older: 15.6 million. 8.2 percent of all people in this age group have diabetes. Under age 20: 123,000. 0.16 percent of all people in this age group have diabetes.
Prevalence of diabetes by sex in people 20 years or older*	Men: 7.5 million. 8.2 percent of all men have diabetes. Women: 8.1 million. 8.2 percent of all women have diabetes. *These figures do not include the approximately 123,000 cases of diabetes in children and teenagers in the United States.
Prevalence of diabetes by race/ethnicity in people 20 years or older	Non-Hispanic whites: 11.3 million. 7.8 percent of all non-Hispanic whites have diabetes. Non-Hispanic blacks: 2.3 million. 10.8 percent of all non-Hispanic blacks have diabetes. On average, non-Hispanic blacks are 1.7 times as likely to have diabetes as non-Hispanic whites of similar age. Mexican Americans: 1.2 million. 10.6 percent of all Mexican Americans have diabetes. On average, Mexican Americans are 1.9 times as likely to have diabetes as non-Hispanic whites of similar age. Other Hispanic/Latino Americans: On average, Hispanic/Latino Americans are almost twice as likely to have diabetes as non-Hispanic whites of similar age. (Sufficient data are not currently available to derive more specific estimates.) American Indians and Alaska Natives: 9 percent of American Indians and Alaska Natives have diagnosed diabetes. On average, American Indians and Alaska Natives are 2.8 times as likely to have diagnosed diabetes as non-Hispanic whites of similar age. Asian Americans and Pacific Islanders: Prevalence data for diabetes among Asian Americans and Pacific Islanders are limited. Some groups within this population are at increased risk for diabetes. For example, data collected from 1988 to 1995 suggest that Native Hawaiians are twice as likely to have diagnosed diabetes as white residents of Hawaii.
The four types of diabetes	Type 1 diabetes was previously called insulin-dependent diabetes mellitus (IDDM) or juvenile-onset diabetes. Type 1 diabetes may account for 5 to 10 percent of all diagnosed cases of diabetes. Risk factors are less well defined for type 1 diabetes than for type 2 diabetes, but autoimmune, genetic, and environmental factors are involved in the development of this type of diabetes. Type 2 diabetes was previously called non-insulin-dependent diabetes mellitus (NIDDM) or adult-onset diabetes. Type 2 diabetes may account for about 90 to 95 percent of all diagnosed cases of diabetes. Risk factors for type 2 diabetes include older age, obesity, family history of diabetes, prior history of gestational diabetes, impaired glucose tolerance, physical inactivity, and race/ethnicity. African Americans, Hispanic/Latino Americans, American Indians, and some Asian Americans and Pacific Islanders are at particularly high risk for type 2 diabetes. Gestational diabetes develops in 2 to 5 percent of all pregnancies but disappears when a pregnancy is over. Gestational diabetes occurs more frequently in African Americans, Hispanic/Latino Americans, American Indians, and persons with a family history of diabetes. Obesity is also associated with higher risk. Women who have had gestational diabetes are at increased risk for later developing type 2 diabetes. In some studies, nearly 40 percent of women with a history of gestational diabetes developed diabetes in the future. "Other specific types" of diabetes result from specific genetic syndromes, surgery, drugs, malnutrition, infections, and other illnesses. Such types of diabetes may account for 1 to 2 percent of all diagnosed cases of diabetes.
Complications of diabetes	Heart disease Heart disease is the leading cause of diabetes-related deaths. Adults with diabetes have heart disease death rates about 2 to 4 times as high as those of adults without diabetes. Stroke The risk of stroke is 2 to 4 times higher in people with diabetes. High blood pressure An estimated 60 to 65 percent of people with diabetes have high blood pressure. Blindness Diabetes is the leading cause of new cases of blindness in adults 20 to 74 years old. Diabetic retinopathy causes from 12,000 to 24,000 new cases of blindness each year. Kidney disease Diabetes is the leading cause of end-stage renal disease, accounting for about 40 percent of new cases. 27,851 people with diabetes developed end-stage renal disease in 1995. In 1995, a total of 98,872 people with diabetes underwent dialysis or kidney transplantation. Nervous system disease About 60 to 70 percent of people with diabetes have mild to severe forms of nervous system damage (which often includes impaired sensation or pain in the feet or hands, slowed digestion of food in the stomach, carpal tunnel syndrome, and other nerve problems). Severe forms of diabetic nerve disease are a major contributing cause of lower extremity amputations. Amputations More than half of lower limb amputations in the United States occur among people with diabetes. From 1993 to 1995, about 67,000 amputations were performed each year among people with diabetes. Dental disease Periodontal disease (a type of gum disease that can lead to tooth loss) occurs with greater frequency and severity among people with diabetes. Periodontal disease has been reported to occur among 30 percent of people age 19 years or older with type 1 diabetes. Complications of pregnancy The rate of major congenital malformations in babies born to women with preexisting diabetes varies from 0 to 5 percent among women who receive preconception care to 10 percent among women who do not receive preconception care. Between 3 and 5 percent of pregnancies among women with diabetes result in death of the newborn; the rate for women who do not have diabetes is 1.5 percent. Other complications Diabetes can directly cause acute life-threatening events, such as diabetic ketoacidosis* and hyperosmolar nonketotic coma.* People with diabetes are more susceptible to many other illnesses. For example, they are more likely to die of pneumonia or influenza than people who do not have diabetes. *Diabetic ketoacidosis and hyperosmolar nonketotic coma are medical conditions that can result from biochemical imbalance in uncontrolled diabetes.
Cost	Total (direct and indirect): $98 billion (United States, 1997). Direct medical costs: $44 billion. Indirect costs: $54 billion (disability, work loss, premature mortality). This estimate, provided by the American Diabetes Association, is in contrast to higher estimates cited elsewhere that are based on all health care costs incurred by people with diabetes, including costs not resulting from diabetes.
New diagnostic criteria for diabetes*	The new diagnostic criteria for diabetes include the following changes: The routine diagnostic test for diabetes is now a fasting plasma glucose test rather than the previously recommended oral glucose tolerance test. (However, in certain clinical circumstances, physicians may still choose to perform the oral glucose tolerance test.) A confirmed fasting plasma glucose value of greater than or equal to 126 milligrams/deciliter (mg/dL) indicates a diagnosis of diabetes. Previously, a value of greater than or equal to 140 mg/dL had been required for diagnosis. In the presence of symptoms of diabetes, a confirmed nonfasting plasma glucose value of greater than or equal to 200 mg/dL indicates a diagnosis of diabetes. When a doctor chooses to perform an oral glucose tolerance test (by administering 75 grams of anhydrous glucose dissolved in water, in accordance with World Health Organization standards, and then measuring the plasma glucose concentration 2 hours later), a confirmed** glucose value of greater than or equal to 200 mg/dL indicates a diagnosis of diabetes. In pregnant women, different requirements are used to identify the presence of gestational diabetes. For further information about the new diagnostic criteria for diabetes, please see the "Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus," in the References. *Except in certain specified circumstances, abnormal tests must be confirmed by repeat testing on another day.
Treatment of diabetes	Diabetes knowledge, treatment, and prevention strategies advance daily. Treatment is aimed at keeping blood glucose near normal levels at all times. Training in self-management is integral to the treatment of diabetes. Treatment must be individualized and must address medical, psychosocial, and lifestyle issues. Treatment of type 1 diabetes: Lack of insulin production by the pancreas makes type 1 diabetes particularly difficult to control. Treatment requires a strict regimen that typically includes a carefully calculated diet, planned physical activity, home blood glucose testing several times a day, and multiple daily insulin injections. Treatment of type 2 diabetes: Treatment typically includes diet control, exercise, home blood glucose testing, and, in some cases, oral medication and/or insulin. Approximately 40 percent of people with type 2 diabetes require insulin injections.
Impaired fasting glucose	Impaired fasting glucose is a new diagnostic category in which persons have fasting plasma glucose values of 110–125 mg/dL. These glucose values are greater than the level considered normal but less than the level that is diagnostic of diabetes. It is estimated that 13.4 million adults, 7.0 percent of this population, have impaired fasting glucose. Scientists are trying to learn how to predict which of these persons will go on to develop diabetes and how to prevent such progression.
Appendix	How were the estimates in this fact sheet derived? Periodically, the Federal Government conducts surveys to determine the health of Americans. Such surveys involve questionnaires and medical tests. Most of the diabetes prevalence and incidence estimates presented in this fact sheet were developed by analyzing the newest available national survey data and then adjusting for changes in the population based on 1997 census estimates. The prevalence of diagnosed diabetes represents the number who said they had diabetes. The prevalence of undiagnosed diabetes represents the number of people who said they did not have diabetes, but when given a fasting plasma glucose test, they did in fact have abnormally elevated blood glucose levels (defined as fasting plasma glucose levels greater than or equal to 126 mg/dL). Other estimates presented in this fact sheet were based on individual surveys, research projects, and registry data. A listing of references and additional data sources is below. Most of the national diabetes prevalence estimates are based on Harris MI, et al. Has the number of persons with diabetes changed since the Diabetes Statistics Fact Sheet issued in 1995? Between the 1995 and 1997 fact sheets, the number of persons with diagnosed diabetes increased from 8 million to 10.3 million, but the number of persons with undiagnosed diabetes decreased. For the 1995 Diabetes Statistics Fact Sheet, the number of persons with undiagnosed diabetes was estimated from research using the oral glucose tolerance test to identify undiagnosed diabetes. In contrast, for the present Diabetes Statistics Fact Sheet, the number of persons with undiagnosed diabetes was estimated from research using the fasting plasma glucose test, according to recently enacted recommendations. These tests are not equivalent, however, and fewer cases of undiagnosed diabetes are identified using the fasting plasma glucose test. An enhanced national effort to identify previously undiagnosed persons may also have contributed to a decrease in the number of persons with undiagnosed diabetes. Continued efforts to identify persons with undiagnosed diabetes, the implementation of new guidelines for screening, and the use of an easier and less expensive diagnostic test are all likely to lead to even further decreases in the number of persons with undiagnosed diabetes and increases in the number of persons with diagnosed diabetes.
References	American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 1998; 21(2): 296-309. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. Diabetes Care 1998; 21(4): 518-524. National Diabetes Data Group, National Institutes of Health. Diabetes in America, 2nd Edition. Bethesda, MD: National Institutes of Health, 1995. NIH Publication No. 95-1468. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20(7):1183-1197. U.S. Department of Health and Human Services. Physical Activity and Health: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 1996. U.S. Renal Data System. USRDS 1997 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1997.
Acknowledgments	The following organizations collaborated in compiling the information for this fact sheet: American Association of Diabetes Educators http://www.aadenet.org American Diabetes Association http://www.diabetes.org Centers for Disease Control and Prevention http://www.cdc.gov/diabetes http://www.cdc.gov/nchswww Department of Veterans Affairs http://www.va.gov/health/diabetes Health Resources and Services Administration http://www.hrsa.dhhs.gov Indian Health Service http://www.ihs.gov Juvenile Diabetes Foundation International http://www.jdfcure.org National Council of La Raza http://www.nclr.org National Diabetes Education Program: A joint program of NIH & CDC http://ndep.nih.gov http://www.cdc.gov/diabetes National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health http://www.niddk.nih.gov U.S. Department of Health and Human Services Office of Minority Health http://www.omhrc.gov
	National Diabetes Information Clearinghouse 1 Information Way Bethesda, MD 20892-3560 E-mail: National Diabetes Information Clearinghouse The National Diabetes Information Clearinghouse (NDIC) is a service of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). NIDDK is part of the National Institutes of Health under the U.S. Department of Health and Human Services. Established in 1978, the clearinghouse provides information about diabetes to people with diabetes and their families, health care professionals, and the public. NDIC answers inquiries; develops, reviews, and distributes publications; and works closely with professional and patient organizations and Government agencies to coordinate resources about diabetes. Publications produced by the clearinghouse are reviewed carefully for scientific accuracy, content, and readability. This e-text is not copyrighted. The clearinghouse encourages users of this e-pub to duplicate and distribute as many copies as desired.
	NIH Publication No. 99-3892 March 1999 e-text posted: September 1999